Jibo Medical 2026H1: Revenue of RMB 178 million, up 4.70% YoY, Net Profit Attributable to Shareholders of the Parent Company up 18.44% YoY.

Source: Jibo Medical 2026 Interim Report

DentalGoodNews｜Guangdong Jibo Medical Group Co., Ltd. (hereinafter referred to as "Jibo Medical") released its 2026 semi-annual report on August 20, 2026. The report shows that the company achieved operating revenue of RMB 178 million in the first half of the year, a year-on-year increase of 4.70%; net profit attributable to shareholders of the listed company was RMB 16.3156 million, a year-on-year increase of 18.44%, with growth outpacing revenue; gross margin improved from 33.08% in the same period last year to 33.24%.

The company's net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was RMB 14.4904 million, a year-on-year increase of 14.49%. Basic earnings per share during the period were RMB 0.28, up 16.67% year-on-year; Weighted Average Return on Equity (ROE) improved from 8.57% in the same period last year to 9.57%.

In terms of cash flow, Net Cash Flow from Operating Activities was RMB 39.6874 million, up 0.44% year-on-year; Net Cash Flow from Investing Activities was -RMB 9.5584 million (compared to RMB 6.0721 million in the same period last year), representing a change of -257.41%. The company stated that this was mainly due to increased investment in wealth management products and large-denomination certificates of deposit during the period.

Source: Jibo Medical 2026 Interim Report

As of the end of the reporting period, the company's total assets stood at RMB 411 million, up 1.38% year-on-year; total liabilities were RMB 253 million, up 3.95% year-on-year; net assets attributable to shareholders of the listed company were RMB 158 million, down 2.45% year-on-year; the consolidated debt-to-asset ratio rose from 59.96% at the end of the previous year to 61.48%.

Source: Jibo Medical 2026 Interim Report

In terms of costs and expenses, the company's operating costs in the first half of the year were RMB 119 million, up 4.46% year-on-year, a growth rate lower than the 4.70% increase in operating revenue, driving gross margin up from 33.08% to 33.24%; selling expenses were RMB 24.1461 million, down 1.28% year-on-year; administrative expenses were RMB 16.7034 million, up 6.44% year-on-year; financial expenses were RMB 2.5078 million, up 17.07% year-on-year.

In terms of impairment gains and losses, credit impairment losses were -RMB 17,000, narrowing by 61.93% compared to -RMB 44,700 in the same period last year; Asset Impairment Loss turned from a loss of RMB 9,015.73 in the same period last year to a gain of RMB 12,769.64 in the current period. In addition, other income was RMB 351,900, up 120.38% year-on-year; investment income was RMB 1.3912 million, down 8.69% year-on-year; fair value change gains were RMB 1.5749 million, up 255.27% year-on-year; asset disposal gains turned from a loss of RMB 6,570.89 in the same period last year to a gain of RMB 6,573.07 in the current period.

Source: Jibo Medical 2026 Interim Report

As of the end of the reporting period, the company operated a total of 33 oral medical institutions, with 257 practicing physicians and 455 dental chairs, covering core cities in the Guangdong-Hong Kong-Macao Greater Bay Area including Foshan, Guangzhou, Zhuhai, Zhongshan, Jiangmen, Zhaoqing, and Dongguan. In terms of personnel efficiency, the company had 1,198 employees at the end of the reporting period, an increase of 53 from the beginning of the period; among them, 940 were medical staff, with their proportion of total employees rising from 76.86% at the beginning of the period to 78.46%.

According to previous reports by DGN, Jibo Medical announced on April 24, 2026 its plan to acquire a 51% equity stake in Guangzhou Dihua Oral Clinic for RMB 408,000, with a performance commitment clause requiring annual net profit of no less than RMB 160,000 from 2026 to 2030. The current financial report discloses that the company acquired a 51% equity stake in Guangzhou Dihua Oral Clinic Co., Ltd. during the period and achieved control over it, with Guangzhou Dihua consolidated into the company's financial statements starting April 1, 2026.